When.com Web Search

  1. Ads

    related to: treatment options available for asthma

Search results

  1. Results From The WOW.Com Content Network
  2. If You're Living With Asthma, Here's Every Single Treatment ...

    www.aol.com/youre-living-asthma-heres-every...

    Here's what you need to know about every asthma treatment option available to you, from over-the-counter medications to natural remedies, doctor-prescribed medications and more. ... These are some ...

  3. Anti-asthmatic agent - Wikipedia

    en.wikipedia.org/wiki/Anti-asthmatic_agent

    An anti-asthmatic agent, also known as an anti-asthma drug, refers to a drug that can aid in airway smooth muscle dilation to allow normal breathing during an asthma attack or reduce inflammation on the airway to decrease airway resistance for asthmatic patients, or both. The goal of asthmatic agents is to reduce asthma exacerbation frequencies ...

  4. Bronchial thermoplasty - Wikipedia

    en.wikipedia.org/wiki/Bronchial_Thermoplasty

    Bronchial thermoplasty [1] is a treatment for severe asthma approved by the FDA in 2010 involving the delivery of controlled, therapeutic radiofrequency energy to the airway wall, thus heating the tissue and reducing the amount of smooth muscle present in the airway wall.

  5. Everything You Need to Know About Asthma, from Symptoms to ...

    www.aol.com/everything-know-asthma-symptoms...

    For premium support please call: 800-290-4726 more ways to reach us

  6. Long-acting beta-adrenoceptor agonist - Wikipedia

    en.wikipedia.org/wiki/Long-acting_beta...

    With the exception of formoterol, LABAs are not recommended for the treatment of acute asthma exacerbations because of their slower onset of action compared to salbutamol. Their long duration of action is due to the addition of a long lipophilic side-chain that binds to an exosite on adrenergic receptors.

  7. First Advanced Oral Treatment For Asthma - Sanofi's ... - AOL

    www.aol.com/first-advanced-oral-treatment-asthma...

    Wednesday, Sanofi SA (NASDAQ:SNY) reported results from the Phase 2 study of oral rilzabrutinib in adult patients with uncontrolled moderate-to-severe asthma. Two doses of rilzabrutinib, 800 mg ...

  1. Ads

    related to: treatment options available for asthma